Press "Enter" to skip to content

An Associated Press study finds.

Abortion rate declines in almost every continuing state Abortions have declined in says where new laws produce it harder to have them – but they’ve also waned in says where abortion rights are protected, an Associated Press study finds. Everywhere Nearly, in red says and blue, abortions are down since 2010. Explanations vary. Abortion-rights advocates attribute it to expanded access to effective contraceptives and a drop in unintended pregnancies. Some foes of abortion say there has been a change in societal attitudes, with an increase of women choosing to carry their pregnancies to term. Many of the states that have been most aggressive in passing anti-abortion laws and regulations – including Indiana, Missouri, Ohio, and Oklahoma – have seen their abortion numbers drop by more than 15 % since 2010.Atrasentan, a substance discovered by Abbott researchers, is being evaluated in a Stage 2b study in patients with diabetic kidney disease. ‘Clinical experience with AP214 in cardiac surgery patients suggests that it has the potential to become the first compound specifically approved to prevent acute kidney injury, a long-standing unmet want in the medical community,’ stated John Leonard, M.D., senior vice president, pharmaceuticals, development and research, Abbott. ‘This acquisition complements and broadens Abbott’s late-stage renal care pipeline and builds on our existing knowledge in treating kidney disease.’ ‘We are very worked up about the sale of AP214 to such a prominent global healthcare firm as Abbott, which has key development competencies to keep the development of this drug applicant for the advantage of patients and doctors in the renal therapeutic region,’ said Ingelise Saunders, CEO of Actions Pharma.